CM383
/ Keymed Biosciences
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
March 19, 2025
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Keymed Biosciences Co.Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders • Cognitive Disorders
October 15, 2024
Single Dose Escalation Study of CM383 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=44 | Recruiting | Sponsor: Keymed Biosciences Co.Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
October 01, 2024
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Keymed Biosciences Co.Ltd
New P1 trial • Alzheimer's Disease • CNS Disorders • Cognitive Disorders
May 14, 2024
Single Dose Escalation Study of CM383 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=44 | Not yet recruiting | Sponsor: Keymed Biosciences Co.Ltd
New P1 trial • Alzheimer's Disease • CNS Disorders
1 to 4
Of
4
Go to page
1